Search results
Diabetic ketoacidosis (DKA) is a frequent and potentially life-threatening complication of type 1 diabetes. Though preventable and despite advances in monitoring technologies, insulin therapeutics and insulin delivery systems, the rates of both community and hospital acquired DKA remain largely unchanged. Although mortality today is relatively
Ketoacidosis/ AG persists & FS BG 70 to 150 mg/dL: Start D10W or D10NS @ 150 - 250 mL/h and/or consider reducing insulin rate by 1⁄2. Keep Serum glucose between 150 – 200 mg/dL. If cannot maintain glucose > 150 mg/dL despite D10 and diet then titrate insulin down to a minimum of 0.5 unit/hr.
DIABETIC KETOACIDOSIS – INITIAL MANAGEMENT GUIDE. DIAGNOSIS OF DKA BLOOD GLUCOSE(BG) > 11*- (glucose may be normal in a known diabetic) + ACIDOSIS - pH <7.3 or HCO3-<15mmol/l + KETONAEMIA – Bld Ketones> 3mmol/l. *If Hyperglycaemic (>35mmol/L) in the absence of significant ketosis or acidosis – Consider Hyperosmolar Hyperglycaemic State ...
22 maj 2020 · This is a subcutaneous (SubQ) insulin protocol that replaces insulin drip needs for mild to moderate DKA. Procedures are adapted for COVID-related considerations of minimizing risk to staff while optimizing patient safety and health.
Diabetic Ketoacidosis (DKA) Two Bag System Protocol [3361] DKA: Blood glucose greater than 250 mg/dL, arterial or venous pH less than 7.3, serum bicarbonate less than 15 mEq/L anion gap greater than 12 and ketonuria or ketonemia. Discontinue all previous insulin orders and oral diabetes medications.
DKA is a life threatening acute complication of diabetes which is usually characterized by hyperglycemia, dehydration and acidosis. The cause of DKA is a deficiency of insulin, with
intravenous insulin, cbg and ketones monitoring record sheet Guide: Only use for patients on intravenous insulin regimen (use different chart for patients on subcutaneous insulin)
